A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects

NCT03748745 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interactions

Interventions

DRUG: SH229
DRUG: SH229
DRUG: Daclatasvir dihydrochloride
DRUG: Daclatasvir dihydrochloride

Sponsor

Nanjing Sanhome Pharmaceutical, Co., Ltd.